Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
04/2014
04/24/2014WO2013049307A3 Enhanced immune memory development by aptamer targeted mtor inhibition of t cells
04/24/2014WO2012125730A3 Reactor systems
04/24/2014WO2012112512A3 Small interfering rnas with target-specific seed sequences
04/24/2014WO2012078703A3 Inhibiting chromosome instability in ovarian cancer
04/24/2014US20140113282 Labelled nucleotides
04/24/2014US20140112951 Vaccine and drug delivery by topical application of vectors and vector extracts
04/24/2014US20140112917 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
04/24/2014US20140112904 Method for enhancing the cleavage activity of i-crei derived meganucleases
04/23/2014EP2722395A1 Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection
04/23/2014EP2722335A1 Process for preparing phosphate compound bearing isotope
04/23/2014EP2721168A1 Methods of producing carbamoyl phosphate and urea
04/23/2014EP2721156A2 Antisense modulation of fibroblast growth factor receptor 4 expression
04/23/2014EP2721046A1 Methods for chemical synthesis of biologically active compounds using supramolecular protective groups and novel compounds obtainable thereby
04/23/2014CN102962015B DNA (Deoxyribose Nucleic Acid) or RNA (Ribose Nucleic Acid) synthesizer with fixed nanometer material microballoons serving as base
04/22/2014US8704063 Maize variety inbred PH13C0
04/22/2014US8704059 Maize hybrid X05C007
04/22/2014US8704058 Maize hybrid X00C165
04/22/2014US8704057 Maize hybrid X18C111
04/22/2014US8704056 Maize hybrid X95C359
04/22/2014US8704044 Nucleic acids that encode ERS1 from maize and their uses
04/22/2014US8704043 Plants having increased yield-related traits and a method for making the same
04/22/2014US8704041 Methods and compositions for targeted polynucleotide modification
04/22/2014US8703931 Method for purification of nucleic acids, particularly from fixed tissue
04/22/2014US8703930 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
04/22/2014US8703929 Compositions comprising siRNA and plasmids
04/22/2014US8703928 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
04/22/2014US8703927 Isolated nucleotide sequences encoding GDF traps
04/22/2014US8703926 Modified lecithin-cholesterol acyltransferase enzymes
04/22/2014US8703925 Chemically-enhanced primer compositions, methods and kits
04/22/2014US8703921 Compositions and methods for delivering inhibitory oligonucleotides
04/22/2014US8703905 Endoplasmic reticulum localization signals
04/22/2014US8703735 Antisense antiviral compounds and methods for treating a filovirus infection
04/22/2014US8703734 Nanoprobes for detection or modification of molecules
04/22/2014US8703732 Composition for enhancing TRAIL sensitivity comprising inhibitors for expression or activity of TIP41 as a target gene of TRAIL sensitizer
04/22/2014US8703731 Sphingosine-bound siRNA
04/22/2014US8703730 Complement antagonists and uses thereof
04/22/2014US8703729 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
04/22/2014US8703728 Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
04/22/2014US8703489 Methods and compositions for targeted single-stranded cleavage and targeted integration
04/22/2014US8703482 Human artificial chromosome (HAC) vector
04/22/2014US8703471 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
04/22/2014US8703462 Generation of random double-strand breaks in DNA using enzymes
04/22/2014US8703460 Method for the production of an additive for the enzymatic decomposition of mycotoxins, additive, and use thereof
04/22/2014US8703459 Catalytic domains of beta(1,4)-galactosyltransferase I having altered metal ion specificity
04/22/2014US8703449 Bioabsorbable polymer containing 2-hydroxyacid monomers
04/22/2014US8703439 Point of care iodine sensor
04/22/2014US8703423 Method of detecting a functional filamentous fungus, method of evaluating a product containing a functional filamentous fungus, and primer pair
04/22/2014US8703422 Methods and processes for calling bases in sequence by incorporation methods
04/22/2014US8703421 Compositions, kits and related methods for the detection and/or monitoring of Salmonella
04/22/2014US8703420 Methods and reagents for the detection of Salmonella spp
04/22/2014US8703416 Method for purification and identification of sperm cells
04/22/2014US8703197 Branched polyamines for delivery of biologically active materials
04/22/2014US8703151 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
04/22/2014US8703150 Methods of using Bacillus anthracis protective antigen sequences for vaccination
04/22/2014US8703131 Nanobodies against tumor necrosis factor-alpha
04/22/2014CA2595906C Libraries and methods for isolating antibodies
04/22/2014CA2580713C Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability
04/22/2014CA2546287C Reduction of dermal scarring
04/22/2014CA2507125C Ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors
04/22/2014CA2469785C Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
04/22/2014CA2345209C Antisense modulation of integrin .alpha.4 expression
04/18/2014CA2829852A1 Dual probe assay for the detection of hcv
04/17/2014WO2014059356A2 Selective antisense compounds and uses thereof
04/17/2014WO2014059353A2 Oligomeric compounds comprising bicyclic nucleosides and uses thereof
04/17/2014WO2014059341A2 Antisense compounds and uses thereof
04/17/2014WO2014058355A1 Method for the quantitive analysis of terminal nucleotides of a g chain of human telomeric dna
04/17/2014WO2014057315A1 A nucleotide sequence and a process thereof
04/17/2014WO2014028773A3 Lignin degrading enzymes from macrophomina phaseolina and uses thereof
04/17/2014WO2014022475A3 Compositions and methods for conformationally stabilizing primate immunodeficiency virus envelope glycoprotein trimers
04/17/2014WO2014018673A3 Fusion proteins and methods thereof
04/17/2014WO2013006619A9 Rna-yy1 interactions
04/17/2014WO2012106725A3 Methods and compositions for treating occular disorders
04/17/2014US20140107331 Photoresponsive nucleic acid manufacturing method
04/17/2014US20140107181 Methods and means for treatment of osteoarthritis
04/17/2014US20140106450 Compositions and Methods for Inhibiting Expression of a Target Gene
04/17/2014US20140106431 High fidelity thermostable ligase and uses thereof
04/17/2014US20140106341 Stabilized bioactive peptides and methods of identification, synthesis, and use
04/16/2014EP2718306A1 Methods of purification of native or mutant forms of diphtheria toxin
04/16/2014EP2717923A2 Methods for modulating kallikrein (klkb1) expression
04/16/2014EP2717882A1 Rna interference mediated inhibition of isocitrate dehydrogenase (idh1) gene expression
04/16/2014CN1833034B Probes, libraries and kits for analysis of mixtures of nucleic acids and methods for constructing the same
04/16/2014CN103732610A Methods of purification of native or mutant forms of diphtheria toxin
04/15/2014US8697962 Maize hybrid X08C896
04/15/2014US8697949 Temporal regulation of gene expression by MicroRNAs
04/15/2014US8697947 Plants having increased yield-related traits and a method for making the same
04/15/2014US8697860 Diagnosis and treatment of disease
04/15/2014US8697859 MicroRNA and methods for inhibiting same
04/15/2014US8697858 Antisense antiviral compound and method for treating influenza viral infection
04/15/2014US8697856 Plasmodium vivax hybrid circumsporozoite protein and vaccine
04/15/2014US8697855 Anti-CD151 antibodies and their use in the treatment of cancer
04/15/2014US8697853 TAL effector-mediated DNA modification
04/15/2014US8697851 MiRNA-regulated differentiation-dependent self-deleting cassette
04/15/2014US8697850 Process for preparing L-amino acids
04/15/2014US8697836 Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response
04/15/2014US8697667 Cyclodextrin-modified polyamines for delivery of therapeutic molecules
04/15/2014US8697666 Anti-cancer oligodeoxynucleotides
04/15/2014US8697664 Targeted binding agents directed to PDGRF-alpha and uses thereof
04/15/2014US8697663 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
04/15/2014US8697655 Method of selecting polypeptide sequence, and metal oxide or silicon-containing compound binding peptide and use thereof
04/15/2014US8697650 HSA-related compositions and methods of use
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 899